6/13 Drugs.com - Pharma News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Drugs.com - Pharma News 61% of American Adults Look Online for Health Information June 12, 2009 at 3:32 pm Washington,  June 11, 2009 - A majority of American adults look online for health information and most are accessing reviews and comments posted by fellow consumers. According to a report released today by the Pew Research Center's Internet &... Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust June 12, 2009 at 11:40 am PLYMOUTH MEETING, Pa., June 12 /PRNewswire-FirstCall/ -- Genaera Corporation ("the Company") (NASDAQ:GENR) today announced that the Company's Board of Directors voted to dissolve the Company. At a Special Meeting of Stockholders held on June 4,... Oscient Pharmaceuticals Discontinues Sales Force Promotion for Antara and Factive June 12, 2009 at 11:19 am WALTHAM, Mass.--(BUSINESS WIRE)--Jun 11, 2009 - Oscient Pharmaceuticals Corporation (NASDAQ: OSCI) today announced that it will discontinue sales force promotion of its two products: ANTARA® (fenofibrate) capsules, a cardiovascular product and... ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound June 12, 2009 at 11:19 am WALTHAM, Mass.--(BUSINESS WIRE)--Jun 11, 2009 - ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today announced that the Company has elected to discontinue further internal development of... Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM) June 12, 2009 at 9:36 am New drug is first injectable product approved for sale in the United Statesfor treatment of pain and fever NASHVILLE, Tenn., June 11 /PRNewswire/ -- Cumberland Pharmaceuticals (www.cumberlandpharma.com) today announced the U.S. Food and Drug...   This email was sent to skripayura.drugsnews@blogger.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.